Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Irinotecan and Flavopiridol in Advanced Hepatoma
NCT00087282Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Jun 2004
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of alvocidib in hepatocellular carcinoma (HCC), sponsored by Memorial Sloan Kettering Cancer Center. Started Jun 2004; status: completed.
02
Drugs
alvocidib
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT00087282.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00087282.